These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 453542)

  • 1. Computerized mass spectrometric assay for sulindac and its metabolites in human plasma.
    Walker RW; Gruber VF; Rosenberg A; Wolf FJ; VandenHeuvel WJ
    Anal Biochem; 1979 Jun; 95(2):579-86. PubMed ID: 453542
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of sulindac and its metabolites in human plasma and urine by high-performance liquid chromatography.
    Swanson BN; Boppana VK
    J Chromatogr; 1981 Sep; 225(1):123-30. PubMed ID: 7298740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thin layer and densitometry for quantitative determination of drugs. I. Identification and determination of sulindac and its metabolites in plasma].
    Corti P; Lencioni E; Zamboni R; Lazzeri L
    Boll Chim Farm; 1983 May; 122(5):229-36. PubMed ID: 6639782
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatography of sulindac and its sulphone and sulphide metabolites in plasma.
    Grgurinovich N
    J Chromatogr; 1987 Feb; 414(1):211-6. PubMed ID: 3571386
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of sulindac and its metabolites in serum by high-performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Chromatogr; 1979 Apr; 171():490-3. PubMed ID: 546862
    [No Abstract]   [Full Text] [Related]  

  • 6. Liquid chromatographic determination of sulindac and metabolites in serum.
    Clark CR; McMillian CL; Hoke JF; Campagna KD; Ravis WR
    J Chromatogr Sci; 1987 Jun; 25(6):247-51. PubMed ID: 3611280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarographic analysis of sulindac in pharmaceutical products and differential pulse polarographic analysis of sulindac and its metabolites in plasma.
    Zamboni R; Corti P; Nucci L
    Boll Chim Farm; 1983 Oct; 122(10):505-11. PubMed ID: 6671033
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.
    Stubbs RJ; Ng LL; Entwistle LA; Bayne WF
    J Chromatogr; 1987 Jan; 413():171-80. PubMed ID: 3558666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical methods for the determination of sulindac and metabolites in plasma, urine, bile, and gastric fluid by liquid chromatography using ultraviolet detection.
    Musson DG; Vincek WC; Constanzer ML; Detty TE
    J Pharm Sci; 1984 Sep; 73(9):1270-3. PubMed ID: 6491950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyl sulfoxide inhibits bioactivation of sulindac.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sulindac in ESRD.
    Diskin CJ; Ravis W; Campagna KD; Clark CR
    Nephron; 1988; 50(4):397. PubMed ID: 3237288
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotransformation of sulindac in end-stage renal disease.
    Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
    Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
    Swanson BN; Mojaverian P; Boppana VK
    J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
    Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
    Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic mass-spectrometric analysis: preliminary report on development of novel mass-spectrometric system for biomedical applications.
    Dreyer WJ; Kuppermann A; Boettger HG; Giffin CE; Norris DD; Grotch SL; Theard LP
    Clin Chem; 1974 Aug; 20(8):998-1002. PubMed ID: 4850710
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulindac disposition when given once and twice daily.
    Swanson BN; Boppana VK; Vlasses PH; Holmes GI; Monsell K; Ferguson RK
    Clin Pharmacol Ther; 1982 Sep; 32(3):397-403. PubMed ID: 7049504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
    Duggan DE; Hooke KF; Hwang SS
    Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulindac and indomethacin on renal prostaglandin synthesis.
    Sedor JR; Williams SL; Chremos AN; Johnson CL; Dunn MJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):85-91. PubMed ID: 6428794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulindac is not renal sparing in man.
    Roberts DG; Gerber JG; Barnes JS; Zerbe GO; Nies AS
    Clin Pharmacol Ther; 1985 Sep; 38(3):258-65. PubMed ID: 4028619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa.
    Graham DY; Smith JL; Holmes GI; Davies RO
    Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.